Jenaro Garcia-Huidobro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jenaro Garcia-Huidobro has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Marcia Puchi
Department of Biochemistry and Molecular Biology, Universidad de Concepcion, Concepcion, Chile
3 shared publicationsClaudio Iribarren
Department of Biochemistry and Molecular Biology, Universidad de Concepcion, Concepcion, Chile
2 shared publications- Jessica Zúñiga-Hernández
Pharmacology Laboratory, Biomedical Sciences Department, Faculty of Health Sciences, University of Talca, Talca 3465548, Chile
2 shared publications Maria Imschenetzky
Department of Biochemistry and Molecular Biology, Universidad de Concepcion, Concepcion, Chile
2 shared publicationsPaula Bustos
Department of Biochemistry and Molecular Biology, Universidad de Concepcion, P.O. Box 160-C, Concepcion, Chile
2 shared publicationsVioleta Morin
Department of Biochemistry and Molecular Biology, Universidad de Concepcion, Concepcion, Chile
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (11) , 628
Systematic Evaluation of a Two-Layer LF1/pH-Indicator Paper Assay for Serum Cholinesterase: Influence of Assay Conditions and Sample Background
Paper-based colorimetric devices could support decentralized screening of cholinesterase inhibition after organophosphate (OP) exposure. We systematically evaluated how substrate identity, concentration and volume, reagent hydration, reading time, glycerol addition, and serum volume affect color development in a two-layer platform comprising a glass-fiber (LF1) reaction layer and a pH-indicator detection layer. Acetylcholine chloride (AChCl), butyrylcholine chloride (BChCl), and butyrylcholine iodide were first screened in solution; AChCl and BChCl were then tested on paper with commercial serum and six individual human sera, and color was quantified as blue-channel intensity from scanned images of the pH-indicator. A working configuration using 8 µL of 60 mM substrate, with readings taken after 20 min, was selected based on the observed colorimetric response. AChCl and BChCl did not differ significantly under these conditions, and larger serum volumes gave no consistent improvement. The selected configuration was 4 µL of serum and 8 µL of 60 mM AChCl containing 5% (v/v) glycerol. Commercial serum-only controls without added substrate shifted the indicator from yellow to green, showing a sample-related contribution to the basal indicator color that may influence the final RGB signal. In a separate exploratory comparison using BChCl, blue-channel intensity was not significantly correlated with pre-treatment reference cholinesterase activity in the six human sera. These results provide a working configuration for further microdevice development and highlight the need to account for sample background.
- 3 November 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (11) , 628
Open AccessSystematic Evaluation of a Two-Layer LF1/pH-Indicator Paper Assay for Serum Cholinesterase: Influence of Assay Conditions and Sample Background
Paper-based colorimetric devices could support decentralized screening of cholinesterase inhibition after organophosphate (OP) exposure. We systematically evaluated how substrate identity, concentration and volume, reagent hydration, reading time, glycerol addition, and serum volume affect color development in a two-layer platform comprising a glass-fiber (LF1) reaction layer and a pH-indicator detection layer. Acetylcholine chloride (AChCl), butyrylcholine chloride (BChCl), and butyrylcholine iodide were first screened in solution; AChCl and BChCl were then tested on paper with commercial serum and six individual human sera, and color was quantified as blue-channel intensity from scanned images of the pH-indicator. A working configuration using 8 µL of 60 mM substrate, with readings taken after 20 min, was selected based on the observed colorimetric response. AChCl and BChCl did not differ significantly under these conditions, and larger serum volumes gave no consistent improvement. The selected configuration was 4 µL of serum and 8 µL of 60 mM AChCl containing 5% (v/v) glycerol. Commercial serum-only controls without added substrate shifted the indicator from yellow to green, showing a sample-related contribution to the basal indicator color that may influence the final RGB signal. In a separate exploratory comparison using BChCl, blue-channel intensity was not significantly correlated with pre-treatment reference cholinesterase activity in the six human sera. These results provide a working configuration for further microdevice development and highlight the need to account for sample background.
- Open Access
- 1 May 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Salivary proteomics suggests persistent inflammatory signatures after clinical healing in recurrent aphthous stomatitis: a hypothesis-generating case-control study
Recurrent aphthous stomatitis is a common inflammatory condition of the oral mucosa characterized by painful ulcers that heal spontaneously but recur unpre
- 1 May 2026
- Published by Springer Nature in BMC Oral Health
- Vol. 26 (1)
Open AccessSalivary proteomics suggests persistent inflammatory signatures after clinical healing in recurrent aphthous stomatitis: a hypothesis-generating case-control study
Recurrent aphthous stomatitis is a common inflammatory condition of the oral mucosa characterized by painful ulcers that heal spontaneously but recur unpre
- Open Access
- 23 August 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-16
Polycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms
Polycomb repressive complex 1 (PRC1) plays essential roles in cell fate decisions and development. However, its role in cancer is less well understood. Here, we show that RNF2, encoding RING1B, and canonical PRC1 (cPRC1) genes are overexpressed in breast cancer. We find that cPRC1 complexes functionally associate with ERα and its pioneer factor FOXA1 in ER+ breast cancer cells, and with BRD4 in triple-negative breast cancer cells (TNBC). While cPRC1 still exerts its repressive function, it is also recruited to oncogenic active enhancers. RING1B regulates enhancer activity and gene transcription not only by promoting the expression of oncogenes but also by regulating chromatin accessibility. Functionally, RING1B plays a divergent role in ER+ and TNBC metastasis. Finally, we show that concomitant recruitment of RING1B to active enhancers occurs across multiple cancers, highlighting an under-explored function of cPRC1 in regulating oncogenic transcriptional programs in cancer.
- 23 August 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-16
Open AccessPolycomb complexes associate with enhancers and promote oncogenic transcriptional programs in cancer through multiple mechanisms
Polycomb repressive complex 1 (PRC1) plays essential roles in cell fate decisions and development. However, its role in cancer is less well understood. Here, we show that RNF2, encoding RING1B, and canonical PRC1 (cPRC1) genes are overexpressed in breast cancer. We find that cPRC1 complexes functionally associate with ERα and its pioneer factor FOXA1 in ER+ breast cancer cells, and with BRD4 in triple-negative breast cancer cells (TNBC). While cPRC1 still exerts its repressive function, it is also recruited to oncogenic active enhancers. RING1B regulates enhancer activity and gene transcription not only by promoting the expression of oncogenes but also by regulating chromatin accessibility. Functionally, RING1B plays a divergent role in ER+ and TNBC metastasis. Finally, we show that concomitant recruitment of RING1B to active enhancers occurs across multiple cancers, highlighting an under-explored function of cPRC1 in regulating oncogenic transcriptional programs in cancer.
- 27 July 2016
- Published by Springer Nature in International Journal of Obesity
- Vol. 40 (11) , 1776-1783
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
- 27 July 2016
- Published by Springer Nature in International Journal of Obesity
- Vol. 40 (11) , 1776-1783
Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome
- Open Access
- 5 November 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e46850
The Protease Degrading Sperm Histones Post-Fertilization in Sea Urchin Eggs Is a Nuclear Cathepsin L That Is Further Required for Embryo Development
Proteolysis of sperm histones in the sea urchin male pronucleus is the consequence of the activation at fertilization of a maternal cysteine protease. We previously showed that this protein is required for male chromatin remodelling and for cell-cycle progression in the newly formed embryos. This enzyme is present in the nucleus of unfertilized eggs and is rapidly recruited to the male pronucleus after insemination. Interestingly, this cysteine-protease remains co-localized with chromatin during S phase of the first cell cycle, migrates to the mitotic spindle in M-phase and is re-located to the nuclei of daughter cells after cytokinesis. Here we identified the protease encoding cDNA and found a high sequence identity to cathepsin proteases of various organisms. A phylogenetical analysis clearly demonstrates that this sperm histone protease (SpHp) belongs to the cathepsin L sub-type. After an initial phase of ubiquitous expression throughout cleavage stages, SpHp gene transcripts become restricted to endomesodermic territories during the blastula stage. The transcripts are localized in the invaginating endoderm during gastrulation and a gut specific pattern continues through the prism and early pluteus stages. In addition, a concomitant expression of SpHp transcripts is detected in cells of the skeletogenic lineage and in accordance a pharmacological disruption of SpHp activity prevents growth of skeletal rods. These results further document the role of this nuclear cathepsin L during development.
- 5 November 2012
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (11) , e46850
Open AccessThe Protease Degrading Sperm Histones Post-Fertilization in Sea Urchin Eggs Is a Nuclear Cathepsin L That Is Further Required for Embryo Development
Proteolysis of sperm histones in the sea urchin male pronucleus is the consequence of the activation at fertilization of a maternal cysteine protease. We previously showed that this protein is required for male chromatin remodelling and for cell-cycle progression in the newly formed embryos. This enzyme is present in the nucleus of unfertilized eggs and is rapidly recruited to the male pronucleus after insemination. Interestingly, this cysteine-protease remains co-localized with chromatin during S phase of the first cell cycle, migrates to the mitotic spindle in M-phase and is re-located to the nuclei of daughter cells after cytokinesis. Here we identified the protease encoding cDNA and found a high sequence identity to cathepsin proteases of various organisms. A phylogenetical analysis clearly demonstrates that this sperm histone protease (SpHp) belongs to the cathepsin L sub-type. After an initial phase of ubiquitous expression throughout cleavage stages, SpHp gene transcripts become restricted to endomesodermic territories during the blastula stage. The transcripts are localized in the invaginating endoderm during gastrulation and a gut specific pattern continues through the prism and early pluteus stages. In addition, a concomitant expression of SpHp transcripts is detected in cells of the skeletogenic lineage and in accordance a pharmacological disruption of SpHp activity prevents growth of skeletal rods. These results further document the role of this nuclear cathepsin L during development.
- 19 May 2010
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 111 (5) , 1099-1106
A new nuclear protease with cathepsin L properties is present in HeLa and Caco-2 cells
Recently many authors have reported that cathepsin L can be found in the nucleus of mammalian cells with important functions in cell-cycle progression. In previous research, we have demonstrated that a cysteine protease (SpH-protease) participates in male chromatin remodeling and in cell-cycle progression in sea urchins embryos. The gene that encodes this protease was cloned. It presents a high identity sequence with cathepsin L family. The active form associated to chromatin has a molecular weight of 60 kDa, which is higher than the active form of cathepsin L described until now, which range between 25 and 35 kDa. Another difference is that the zymogen present in sea urchin has a molecular weight of 75 and 90 kDa whereas for human procathepsin L has a molecular weight of 38–42 kDa. Based on these results and using a polyclonal antibody available in our laboratory that recognizes the active form of the 60 kDa nuclear cysteine protease of sea urchin, ortholog to human cathepsin L, we investigated the presence of this enzyme in HeLa and Caco-2 cells. We have identified a new nuclear protease, type cathepsin L, with a molecular size of 60 kDa, whose cathepsin activity increases after a partial purification by FPLC and degrade in vitro histone H1. This protease associates to the mitotic spindle during mitosis, remains in the nuclei in binuclear cells and also translocates to the cytoplasm in non-proliferative cells. J. Cell. Biochem. 111: 1099–1106, 2010.
- 19 May 2010
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 111 (5) , 1099-1106
A new nuclear protease with cathepsin L properties is present in HeLa and Caco-2 cells
Recently many authors have reported that cathepsin L can be found in the nucleus of mammalian cells with important functions in cell-cycle progression. In previous research, we have demonstrated that a cysteine protease (SpH-protease) participates in male chromatin remodeling and in cell-cycle progression in sea urchins embryos. The gene that encodes this protease was cloned. It presents a high identity sequence with cathepsin L family. The active form associated to chromatin has a molecular weight of 60 kDa, which is higher than the active form of cathepsin L described until now, which range between 25 and 35 kDa. Another difference is that the zymogen present in sea urchin has a molecular weight of 75 and 90 kDa whereas for human procathepsin L has a molecular weight of 38–42 kDa. Based on these results and using a polyclonal antibody available in our laboratory that recognizes the active form of the 60 kDa nuclear cysteine protease of sea urchin, ortholog to human cathepsin L, we investigated the presence of this enzyme in HeLa and Caco-2 cells. We have identified a new nuclear protease, type cathepsin L, with a molecular size of 60 kDa, whose cathepsin activity increases after a partial purification by FPLC and degrade in vitro histone H1. This protease associates to the mitotic spindle during mitosis, remains in the nuclei in binuclear cells and also translocates to the cytoplasm in non-proliferative cells. J. Cell. Biochem. 111: 1099–1106, 2010.
- 18 April 2008
- Published by Wiley in Journal of Cellular Physiology
- Vol. 216 (3) , 790-795
Cathepsin L inhibitor I blocks mitotic chromosomes decondensation during cleavage cell cycles of sea urchin embryos
We have previously reported that sperm histones (SpH) degradation after fertilization is catalyzed by a cystein–protease (SpH‐protease). Its inhibition blocks the degradation of SpH in vivo and also aborts sea urchin development at the initial embryonic cell cycles. It remains unknown if this effect is a consequence of the persistence of SpH on zygotic chromatin, or if this protease is involved per‐se in the progression of the embryonic cell cycles. To discriminate among these two options we have inhibited this protease at a time when male chromatin remodeling was completed and the embryos were engaged in the second cell cycle of the cleavage divisions. The role of this enzyme in cell cycle was initially analyzed by immuno‐inhibiting its SpH degrading activity in one of the two blastomeres after the initial cleavage division, while the other blastomere was used as a control. We found that in the blastomere injected with the anti‐SpH‐protease antibodies the cytokinesis was arrested, the chromatin failed to decondense after mitosis and BrdU incorporation into DNA was blocked. Since the N‐terminal sequence and the SpH protease was homologous to the cathepsin L (Cat L) family of proteases, we subsequently investigated if the deleterious effect of the inhibition of this protease is related to its Cat L activity. In this context we analyzed the effect of Cat L inhibitor I (Z–Phe‐Phe–CH2F) on embryonic development. We found that the addition of 100 uM of this inhibitor to the embryos harvested at the time of the initial cleavage division (80 min p.i.) mimics perfectly the effects of the immuno‐inhibition of this enzyme obtained by microinjecting the anti‐SpH–protease antibodies. Taken together these results indicate that the activity of this protease is required for embryonic cell cycle progression. Interestingly, we observed that when this protease was inhibited the chromatin decondensation after mitosis was abolished indicating that the inhibition of this enzyme affects chromosomes decondensation after mitosis. J. Cell. Physiol. 216: 790–795, 2008,
- 18 April 2008
- Published by Wiley in Journal of Cellular Physiology
- Vol. 216 (3) , 790-795
Cathepsin L inhibitor I blocks mitotic chromosomes decondensation during cleavage cell cycles of sea urchin embryos
We have previously reported that sperm histones (SpH) degradation after fertilization is catalyzed by a cystein–protease (SpH‐protease). Its inhibition blocks the degradation of SpH in vivo and also aborts sea urchin development at the initial embryonic cell cycles. It remains unknown if this effect is a consequence of the persistence of SpH on zygotic chromatin, or if this protease is involved per‐se in the progression of the embryonic cell cycles. To discriminate among these two options we have inhibited this protease at a time when male chromatin remodeling was completed and the embryos were engaged in the second cell cycle of the cleavage divisions. The role of this enzyme in cell cycle was initially analyzed by immuno‐inhibiting its SpH degrading activity in one of the two blastomeres after the initial cleavage division, while the other blastomere was used as a control. We found that in the blastomere injected with the anti‐SpH‐protease antibodies the cytokinesis was arrested, the chromatin failed to decondense after mitosis and BrdU incorporation into DNA was blocked. Since the N‐terminal sequence and the SpH protease was homologous to the cathepsin L (Cat L) family of proteases, we subsequently investigated if the deleterious effect of the inhibition of this protease is related to its Cat L activity. In this context we analyzed the effect of Cat L inhibitor I (Z–Phe‐Phe–CH2F) on embryonic development. We found that the addition of 100 uM of this inhibitor to the embryos harvested at the time of the initial cleavage division (80 min p.i.) mimics perfectly the effects of the immuno‐inhibition of this enzyme obtained by microinjecting the anti‐SpH–protease antibodies. Taken together these results indicate that the activity of this protease is required for embryonic cell cycle progression. Interestingly, we observed that when this protease was inhibited the chromatin decondensation after mitosis was abolished indicating that the inhibition of this enzyme affects chromosomes decondensation after mitosis. J. Cell. Physiol. 216: 790–795, 2008,